Cycloserine clinical pharmacology

Revision as of 16:44, 26 December 2013 by Chetan Lokhande (talk | contribs) (Created page with "__NOTOC__ {{Cycloserine}} {{CMG}} ; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GM...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cycloserine
SEROMYCIN ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


[1]


References

  1. ↑ "SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Cycloserine_clinical_pharmacology&oldid=920014"